O Hantz Selected Research

dexelvucitabine

4/2001	Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
1/2000	Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

O Hantz Research Topics

Disease

6	Infections 01/2009 - 01/2000
2	Virus Diseases (Viral Diseases) 01/2009 - 02/2004
2	Hepatitis B 01/2009 - 04/2000
2	Viremia 04/2001 - 01/2000
2	Chronic Hepatitis B 04/2000 - 03/2000
1	Reinfection 01/2009
1	Persistent Infection 02/2004
1	Neoplasms (Cancer) 07/2001
1	Chronic Hepatitis (Chronic Active Hepatitis) 04/2001
1	Hepatocellular Carcinoma (Hepatoma) 04/2001
1	Inflammation (Inflammations) 01/2000

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 01/2009 - 07/2001
3	Lamivudine (Epivir)FDA Link 01/2009 - 03/2000
3	Viral DNAIBA 01/2009 - 01/2000
3	NucleosidesIBA 04/2001 - 03/2000
3	Antiviral Agents (Antivirals)IBA 04/2001 - 01/2000
2	dexelvucitabineIBA 04/2001 - 01/2000
1	AlbuminsIBA 01/2009
1	Amino Acids FDA Link 02/2004
1	EpitopesIBA 02/2004
1	Proteins (Proteins, Gene)FDA Link 02/2004
1	Peptides (Polypeptides)IBA 02/2004
1	AntibodiesIBA 02/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2001
1	Circular DNAIBA 07/2001
1	Epidermal Growth Factor (EGF)IBA 07/2001
1	Transforming Growth Factor alpha (TGF-alpha)IBA 07/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2001
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2001
1	Famciclovir (Famvir)FDA LinkGeneric 04/2000
1	Viral AntigensIBA 01/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2000

Therapy/Procedure

2	Therapeutics 04/2000 - 03/2000